Position in MLYS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,732,777
-$1,191,886 QoQ
Shares Held
101,289
-30.1% QoQ
Ownership
0.115%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#82
of 224 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MLYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARK ASSET MANAGEMENT LP holds $3,592,570 across 2 Biotechnology names. MLYS ranks #1 (76.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MLYS |
Mineralys Therapeutics, Inc.
This page
|
101,289 | $2,732,777 | |
| 2 | ABVX |
Abivax S.A.
|
6,452 | $859,793 |
All Filings in MLYS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,732,777 | 101,289 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,924,663 | 144,875 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $738,112 | 19,465 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||